
Qubit Pharmaceuticals, a new player in Quantum-aided Drug Design
Qubit Pharmaceuticals announced the closing of a pre-seed round with Quantum investment fund Quantonation that will support the market entry of its first platform, ATLAS, a software suite for the discovery and test of drug candidates running on supercomputers to co-design new drugs with pharma and biotech companies. From approximation to